Scandinavian Medical Solutions AS (SMSMED) — Strategic Asset Allocation Index

Latest as of September 2022: 21.1%

Scandinavian Medical Solutions AS (SMSMED) has a Strategic Asset Allocation Index of 21.1% as of September 2022. Strategic assets (PP&E of Dkr13.15 Million plus long-term investments of Dkr-) total Dkr13.15 Million, measured against net assets of Dkr62.19 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Scandinavian Medical Solutions AS (SMSMED) net asset quality to measure how much of total assets are equity-financed.

SAAI

21.1%
Strategic Assets / Net Assets

Strategic Assets

Dkr13.15 Million
PP&E + LT Investments

PP&E

Dkr13.15 Million
DKK

Net Assets

Dkr62.19 Million
DKK

Scandinavian Medical Solutions AS Strategic Asset Allocation Index (2020–2022)

This chart shows how Scandinavian Medical Solutions AS's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2022. As of September 2022, the index stands at 21.1%, representing strategic assets of Dkr13.15 Million against net assets of Dkr62.19 Million DKK. For live market cap and overall valuation, see SMSMED company net worth.

Annual Strategic Asset Allocation Index for Scandinavian Medical Solutions AS (2020–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Scandinavian Medical Solutions AS from 2020 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Scandinavian Medical Solutions AS (SMSMED) shareholders funds for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (DKK) PP&E LT Investments Net Assets Change (pp)
2022 21.1% Dkr13.15 Million Dkr13.15 Million Dkr- Dkr62.19 Million ▲ +20.6 pp
2020 0.5% Dkr24.16K Dkr24.16K Dkr- Dkr4.88 Million
pp = percentage points